138 related articles for article (PubMed ID: 22015022)
1. The secretion of PAPP-A, ADAM12, and PP13 correlates with the size of the placenta for the first month of pregnancy.
Sahraravand M; Järvelä IY; Laitinen P; Tekay AH; Ryynänen M
Placenta; 2011 Dec; 32(12):999-1003. PubMed ID: 22015022
[TBL] [Abstract][Full Text] [Related]
2. Connection between the secretion of few proteins and the growth of the gestational sac and the placenta: scientific observations.
Nor Azlin MI; Das S
Placenta; 2012 Apr; 33(4):317. PubMed ID: 22289272
[No Abstract] [Full Text] [Related]
3. Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation.
Kuc S; Wortelboer EJ; Koster MP; de Valk HW; Schielen PC; Visser GH
BJOG; 2011 May; 118(6):748-54. PubMed ID: 21332636
[TBL] [Abstract][Full Text] [Related]
4. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
5. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
7. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Prenat Diagn; 2010 May; 30(5):413-7. PubMed ID: 20306463
[TBL] [Abstract][Full Text] [Related]
8. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
9. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system.
Cowans NJ; Spencer K
Prenat Diagn; 2007 Mar; 27(3):264-71. PubMed ID: 17278174
[TBL] [Abstract][Full Text] [Related]
10. ADAM12s and PP13 as first trimester screening markers for adverse pregnancy outcome.
Deurloo KL; Linskens IH; Heymans MW; Heijboer AC; Blankenstein MA; van Vugt JM
Clin Chem Lab Med; 2013 Jun; 51(6):1279-84. PubMed ID: 23241612
[TBL] [Abstract][Full Text] [Related]
11. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
12. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia.
Akolekar R; Syngelaki A; Beta J; Kocylowski R; Nicolaides KH
Prenat Diagn; 2009 Dec; 29(12):1103-8. PubMed ID: 19777530
[TBL] [Abstract][Full Text] [Related]
14. Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia.
De Villiers CP; Hedley PL; Placing S; Wøjdemann KR; Shalmi AC; Carlsen AL; Rode L; Sundberg K; Tabor A; Christiansen M
Clin Chem Lab Med; 2017 Nov; 56(1):65-74. PubMed ID: 28704180
[TBL] [Abstract][Full Text] [Related]
15. The value of early second trimester PAPP-A and ADAM12 in screening for pre-eclampsia.
Bestwick JP; George LM; Wu T; Morris JK; Wald NJ
J Med Screen; 2012 Mar; 19(1):51-4. PubMed ID: 22357350
[TBL] [Abstract][Full Text] [Related]
16. ADAM12 and PAPP-A: Candidate regulators of trophoblast invasion and first trimester markers of healthy trophoblasts.
Christians JK; Beristain AG
Cell Adh Migr; 2016 Mar; 10(1-2):147-53. PubMed ID: 26417939
[TBL] [Abstract][Full Text] [Related]
17. First-trimester maternal serum ADAM12-s and PAPP-A levels are altered in pregnancies conceived after assisted reproduction techniques (ART).
Sahraravand M; Laitinen P; Järvelä I; Ryynänen M
Prenat Diagn; 2016 Feb; 36(2):163-9. PubMed ID: 26697810
[TBL] [Abstract][Full Text] [Related]
18. Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hypertensive disorders and small for gestational age outcomes.
Stamatopoulou A; Cowans NJ; Matwejew E; von Kaisenberg C; Spencer K
Hypertens Pregnancy; 2011; 30(4):384-95. PubMed ID: 20701472
[TBL] [Abstract][Full Text] [Related]
19. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
Aghababaei M; Perdu S; Irvine K; Beristain AG
Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
[TBL] [Abstract][Full Text] [Related]
20. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia.
Huppertz B; Meiri H; Gizurarson S; Osol G; Sammar M
Hum Reprod Update; 2013; 19(4):391-405. PubMed ID: 23420029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
